Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'
Peters RJR. et al, (2023), Annals of the Rheumatic Diseases, 82, e210 - e210
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.
Wing PAC. et al, (2023), PLoS pathogens, 19
A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis
Radford‐Smith DE. et al, (2022), Liver International, 42, 1344 - 1354
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease
Goodchild G. et al, (2020), Clinical Medicine, 20, e32 - e39
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis
Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00069 - e00069
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis
Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00020 - e00020